Initiation and Up-Titration of Guideline-Based Medications in Hospitalized Acute Heart Failure Patients　― A Report From the West Tokyo Heart Failure Registry ―-Reference-Cited by-同舟云学术

Initiation and Up-Titration of Guideline-Based Medications in Hospitalized Acute Heart Failure Patients　― A Report From the West Tokyo Heart Failure Registry ―

Published:2023-12-25 Issue:1 Volume:88 Page:22-30
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Ohata Takanori¹,Niimi Nozomi²,Shiraishi Yasuyuki¹,Nakatsu Fumiko³,Umemura Ichiro³,Kohno Takashi⁴,Nagatomo Yuji⁵,Takei Makoto⁶,Ono Tomohiko⁷,Sakamoto Munehisa⁸,Nakano Shintaro⁹,Fukuda Keiichi¹,Kohsaka Shun¹,Yoshikawa Tsutomu¹⁰

Affiliation:

1. Department of Cardiology, Keio University School of Medicine

2. General Internal Medicine, National Hospital Organization Tokyo Medical Center

3. Medical Affairs Division, Novartis Pharma K.K.

4. Department of Cardiovascular Medicine, Kyorin University Faculty of Medicine

5. Department of Cardiology, National Defense Medical College Hospital

6. Department of Cardiology, Saiseikai Central Hospital

7. Department of Cardiology, National Hospital Organization Saitama National Hospital

8. Department of Cardiology, National Hospital Organization Tokyo Medical Center

9. Department of Cardiology, Saitama Medical University International Medical Center

10. Department of Cardiology, Sakakibara Heart Institute

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/88/1/88_CJ-23-0356/_pdf

Reference43 articles.

1. 1. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145: E895–E1032, doi:10.1161/CIR.0000000000001063.

2. 2. McDonagh TA, Metra M, Adamo M, Baumbach A, Böhm M, Burri H, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021; 42: 3599–3726, doi:10.1093/eurheartj/ehab368.

3. 3. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709–717, doi:10.1056/NEJM199909023411001.

4. 4. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349–1355, doi:10.1056/nejm199605233342101.

5. 5. Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 2020; 383: 1413–1424, doi:10.1056/nejmoa2022190.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Guideline-Directed Medical Therapy During Hospitalization Improves Prognosis in Patients With Worsening Heart Failure Requiring Readmissions;Circulation Journal;2024-08-23

2. Optimizing Guideline-Directed Medical Therapy for Heart Failure　― Challenges and Strategies ―;Circulation Journal;2023-12-25